• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[2型糖尿病和肥胖症中的先天性和适应性免疫细胞]

[Cells of innate and adaptive immunity in type 2 diabetes and obesity].

作者信息

Guzmán-Flores Juan Manuel, López-Briones Sergio

机构信息

Departamento de Ciencias Médicas, Universidad de Guanajuato, México.

出版信息

Gac Med Mex. 2012 Jul-Aug;148(4):381-9.

PMID:22976756
Abstract

Both type 2 diabetes mellitus (T2DM) and obesity are a major public health problem in Mexico and around the world for increased incidence. In T2DM, insulin secretion, insulin action or both are altered. Also, in T2DM as well as in obesity a low grade chronic inflammation has been associated. In both conditions there is an important increase of visceral adipose tissue, which induces to an up-regulation of synthesis in proinflammatory molecules. This process involves different subsets of the immune system. The macrophages and monocytes are the best studied, but recently has been reported the involvement of other type of cells; such as neutrophils, mast cells, eosinophils, dendritic cells, NKs, NKT. Also, some T cells subsets, such as Th1, Th2, T regulatory, Th17 and B cells seems to be involved in the low grade chronic inflammation. This review focuses on recent evidences of the role of innate and adaptative immune system cells in the pathology of T2DM and obesity. We concluded with the general proposal of a theoretical model, how the immune cells may participate in inflammation of fat tissue, insulin resistance and T2DM.

摘要

2型糖尿病(T2DM)和肥胖症在墨西哥及全球范围内都是主要的公共卫生问题,其发病率呈上升趋势。在T2DM中,胰岛素分泌、胰岛素作用或两者均发生改变。此外,在T2DM以及肥胖症中,均存在低度慢性炎症。在这两种情况下,内脏脂肪组织均显著增加,这会导致促炎分子合成上调。这一过程涉及免疫系统的不同亚群。巨噬细胞和单核细胞是研究最多的,但最近有报道称其他类型的细胞也参与其中,如中性粒细胞、肥大细胞、嗜酸性粒细胞、树突状细胞、自然杀伤细胞(NK)、自然杀伤T细胞(NKT)。此外,一些T细胞亚群,如辅助性T细胞1型(Th1)、辅助性T细胞2型(Th2)、调节性T细胞、辅助性T细胞17型(Th17)和B细胞似乎也参与了低度慢性炎症。本综述重点关注先天性和适应性免疫系统细胞在T2DM和肥胖症病理过程中作用的最新证据。我们最后提出了一个理论模型的总体设想,即免疫细胞如何参与脂肪组织炎症、胰岛素抵抗和T2DM。

相似文献

1
[Cells of innate and adaptive immunity in type 2 diabetes and obesity].[2型糖尿病和肥胖症中的先天性和适应性免疫细胞]
Gac Med Mex. 2012 Jul-Aug;148(4):381-9.
2
The role of innate immune cells in obese adipose tissue inflammation and development of insulin resistance.固有免疫细胞在肥胖脂肪组织炎症和胰岛素抵抗发展中的作用。
Thromb Haemost. 2013 Mar;109(3):399-406. doi: 10.1160/TH12-09-0703. Epub 2013 Jan 31.
3
The role of inflammatory cytokines in diabetes and its complications.炎症细胞因子在糖尿病及其并发症中的作用。
J Periodontol. 2008 Aug;79(8 Suppl):1527-34. doi: 10.1902/jop.2008.080246.
4
Adipose tissue inflammation: feeding the development of type 2 diabetes mellitus.脂肪组织炎症:促进 2 型糖尿病的发展。
Immunobiology. 2013 Dec;218(12):1497-504. doi: 10.1016/j.imbio.2013.05.002. Epub 2013 May 16.
5
The inflammatory consequences of psychologic stress: relationship to insulin resistance, obesity, atherosclerosis and diabetes mellitus, type II.心理应激的炎症后果:与胰岛素抵抗、肥胖、动脉粥样硬化及II型糖尿病的关系
Med Hypotheses. 2006;67(4):879-91. doi: 10.1016/j.mehy.2006.04.008. Epub 2006 Jun 15.
6
Toll-like receptors, inflammation, metabolism and obesity. toll 样受体、炎症、代谢与肥胖。
Arch Physiol Biochem. 2011 Jul;117(3):151-64. doi: 10.3109/13813455.2011.562514. Epub 2011 May 23.
7
Recent advances in the relationship between obesity, inflammation, and insulin resistance.肥胖、炎症与胰岛素抵抗之间关系的最新进展。
Eur Cytokine Netw. 2006 Mar;17(1):4-12.
8
Innate immunity, insulin resistance and type 2 diabetes.先天性免疫、胰岛素抵抗与2型糖尿病
Trends Endocrinol Metab. 2008 Jan;19(1):10-6. doi: 10.1016/j.tem.2007.10.004. Epub 2007 Dec 21.
9
Immunity as a link between obesity and insulin resistance.免疫作为肥胖症和胰岛素抵抗之间的联系。
Mol Aspects Med. 2012 Feb;33(1):26-34. doi: 10.1016/j.mam.2011.10.011. Epub 2011 Oct 21.
10
Adaptive immunity in obesity and insulin resistance.肥胖与胰岛素抵抗中的适应性免疫。
Nat Rev Endocrinol. 2012 Dec;8(12):709-16. doi: 10.1038/nrendo.2012.114. Epub 2012 Jul 31.

引用本文的文献

1
COVID-19 associated liver injury: An updated review on the mechanisms and management of risk groups.新型冠状病毒肺炎相关肝损伤:风险群体机制与管理的最新综述
Liver Res. 2023 Jul 13;7(3):207-215. doi: 10.1016/j.livres.2023.07.001. eCollection 2023 Sep.
2
An in-depth understanding of the role and mechanisms of T cells in immune organ aging and age-related diseases.深入了解T细胞在免疫器官衰老及与年龄相关疾病中的作用和机制。
Sci China Life Sci. 2025 Feb;68(2):328-353. doi: 10.1007/s11427-024-2695-x. Epub 2024 Sep 2.
3
COVID-19 vaccination in patients with cancer: Opportunities and challenges.
癌症患者的新冠病毒疫苗接种:机遇与挑战。
Front Oncol. 2022 Nov 8;12:1029325. doi: 10.3389/fonc.2022.1029325. eCollection 2022.
4
Poor prognosis indicators of type-2 diabetic COVID-19 patients.2 型糖尿病合并 COVID-19 患者的预后不良指标。
Braz J Med Biol Res. 2022 Jun 22;55:e11819. doi: 10.1590/1414-431X2022e11819. eCollection 2022.
5
The purinergic signalling and inflammation in the pathogenesis and progression of diabetes: key factors and therapeutic targets.嘌呤能信号转导和炎症在糖尿病发病机制和进展中的作用:关键因素和治疗靶点。
Inflamm Res. 2022 Aug;71(7-8):759-770. doi: 10.1007/s00011-022-01587-x. Epub 2022 Jun 1.
6
Impact of metabolic and cardiovascular disease on COVID-19 mortality: A systematic review and meta-analysis.代谢和心血管疾病对 COVID-19 死亡率的影响:系统评价和荟萃分析。
Diabetes Metab Syndr. 2021 Nov-Dec;15(6):102308. doi: 10.1016/j.dsx.2021.102308. Epub 2021 Oct 6.
7
Factors Behind the Higher COVID-19 Risk in Diabetes: A Critical Review.糖尿病患者感染新冠病毒风险更高的背后因素:一项批判性综述
Front Public Health. 2021 Jul 7;9:591982. doi: 10.3389/fpubh.2021.591982. eCollection 2021.
8
COVID-19 Pandemic in Brazil: History, Characteristics, and Evolution.巴西的 COVID-19 大流行:历史、特征和演变。
Adv Exp Med Biol. 2021;1327:35-47. doi: 10.1007/978-3-030-71697-4_3.
9
Clinical Features and Risk Factors of ICU Admission for COVID-19 Patients with Diabetes.伴有糖尿病的 COVID-19 患者 ICU 收治的临床特征和危险因素。
J Diabetes Res. 2020 Dec 11;2020:5237840. doi: 10.1155/2020/5237840. eCollection 2020.
10
Metabolic risk factors and risk of Covid-19: A systematic review and meta-analysis.代谢风险因素与 COVID-19 风险:系统评价和荟萃分析。
PLoS One. 2020 Dec 15;15(12):e0243600. doi: 10.1371/journal.pone.0243600. eCollection 2020.